Global Medical REIT (GMRE) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

GMRE Stock Forecast


Global Medical REIT stock forecast is as follows: an average price target of $11.75 (represents a 36.00% upside from GMRE’s last price of $8.64) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

GMRE Price Target


The average price target for Global Medical REIT (GMRE) is $11.75 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $11.75 to $11.75. This represents a potential 36.00% upside from GMRE's last price of $8.64.

GMRE Analyst Ratings


Buy

According to 3 Wall Street analysts, Global Medical REIT's rating consensus is 'Buy'. The analyst rating breakdown for GMRE stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Global Medical REIT Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 18, 2024Kai KloseBerenberg Bank$11.75$9.4823.95%36.00%
Row per page
Go to

The latest Global Medical REIT stock forecast, released on Oct 18, 2024 by Kai Klose from Berenberg Bank, set a price target of $11.75, which represents a 23.95% increase from the stock price at the time of the forecast ($9.48), and a 36.00% increase from GMRE last price ($8.64).

Global Medical REIT Price Target by Period


1M3M12M
# Anlaysts-11
Avg Price Target-$11.75$11.75
Last Closing Price$8.64$8.64$8.64
Upside/Downside-100.00%36.00%36.00%

In the current month, the average price target of Global Medical REIT stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Global Medical REIT's last price of $8.64. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 19, 2024Alliance Global Partners-BuyInitialise
Sep 18, 2024KeyBancSector WeightSector WeightHold
Aug 01, 2023B. Riley SecuritiesBuyBuyHold
Row per page
Go to

Global Medical REIT's last stock rating was published by Alliance Global Partners on Sep 19, 2024. The company Initialise its GMRE rating from "null" to "Buy".

Global Medical REIT Financial Forecast


Global Medical REIT Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$35.51M$36.32M$36.23M$36.31M$35.41M$33.70M$31.88M$30.34M$29.98M$28.26M$27.35M$24.93M$25.10M$22.05M$21.65M$20.45M$18.20M
Avg Forecast$41.27M$40.55M$39.84M$39.12M$36.81M$36.43M$36.30M$35.51M$35.02M$34.72M$34.38M$33.89M$35.62M$36.05M$36.46M$35.14M$33.04M$32.47M$31.86M$30.58M$30.62M$29.28M$28.33M$25.72M$25.07M$22.04M$21.57M$20.96M$19.35M$17.54M
High Forecast$41.92M$41.19M$40.46M$39.73M$37.39M$37.01M$36.87M$36.56M$35.58M$34.78M$34.38M$33.89M$35.65M$36.05M$37.03M$35.70M$33.56M$32.47M$31.86M$30.58M$30.62M$29.28M$28.33M$25.72M$25.07M$22.04M$21.57M$20.96M$19.35M$17.54M
Low Forecast$40.29M$39.59M$38.89M$38.19M$35.94M$35.57M$35.44M$34.07M$34.20M$34.65M$34.38M$33.89M$35.58M$36.05M$35.60M$34.31M$32.26M$32.47M$31.86M$30.58M$30.62M$29.28M$28.33M$25.72M$25.07M$22.04M$21.57M$20.96M$19.35M$17.54M
# Analysts222211143122422211112222987655
Surprise %-------------0.98%1.00%1.03%1.10%1.09%1.06%1.04%0.99%1.02%1.00%1.06%0.99%1.14%1.02%1.03%1.06%1.04%

Global Medical REIT's average Quarter revenue forecast for Dec 23 based on 4 analysts is $35.62M, with a low forecast of $35.58M, and a high forecast of $35.65M. GMRE's average Quarter revenue forecast represents a 0.32% increase compared to the company's last Quarter revenue of $35.51M (Sep 23).

Global Medical REIT EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143122422211112222987655
EBITDA-------------$26.31M$24.67M$25.16M$25.12M$24.77M$23.65M$22.31M$22.90M$22.07M$20.52M$19.14M$17.73M$5.62M$15.13M$15.09M$15.08M$13.51M
Avg Forecast$28.26M$27.77M$27.28M$26.79M$25.21M$24.95M$24.86M$24.32M$23.99M$23.78M$23.55M$29.93M$24.40M$24.69M$24.97M$27.21M$28.56M$22.33M$21.92M$24.74M$21.06M$20.14M$19.59M$17.69M$17.24M$15.16M$14.83M$18.56M$13.31M$12.07M
High Forecast$28.71M$28.21M$27.71M$27.21M$25.61M$25.34M$25.25M$25.04M$24.36M$23.82M$23.55M$35.92M$24.42M$24.69M$25.36M$32.65M$34.28M$22.33M$21.92M$29.68M$21.06M$20.14M$23.50M$17.69M$17.24M$15.16M$14.83M$22.27M$13.31M$12.07M
Low Forecast$27.59M$27.12M$26.64M$26.16M$24.62M$24.36M$24.27M$23.33M$23.42M$23.73M$23.55M$23.94M$24.37M$24.69M$24.38M$21.77M$22.85M$22.33M$21.92M$19.79M$21.06M$20.14M$15.67M$17.69M$17.24M$15.16M$14.83M$14.85M$13.31M$12.07M
Surprise %-------------1.07%0.99%0.92%0.88%1.11%1.08%0.90%1.09%1.10%1.05%1.08%1.03%0.37%1.02%0.81%1.13%1.12%

4 analysts predict GMRE's average Quarter EBITDA for Dec 23 to be $24.40M, with a high of $24.42M and a low of $24.37M. This is -7.27% lower than Global Medical REIT's previous annual EBITDA (Sep 23) of $26.31M.

Global Medical REIT Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143122422211112222987655
Net Income-------------$3.14M$13.28M$2.13M$-6.22M$9.51M$3.69M$4.12M$5.26M$5.14M$4.01M$3.21M$2.52M$-8.81M$1.66M$2.71M$2.67M$2.23M
Avg Forecast$1.97M$1.97M$1.97M$1.97M$1.64M$1.31M$1.48M$657.37K$328.69K$986.05K$-328.69K$3.86M$986.05K$920.32K$438.27K$3.51M$6.61M$2.13M$3.12M$3.19M$4.26M$3.61M$3.83M$3.02M$2.62M$1.97M$2.19M$3.39M$3.02M$2.10M
High Forecast$2.01M$2.01M$2.01M$2.01M$1.68M$1.34M$1.51M$670.82K$335.41K$1.01M$-318.58K$4.64M$1.01M$939.14K$447.23K$4.22M$7.93M$2.13M$3.12M$3.83M$4.26M$3.61M$4.59M$3.02M$2.62M$1.97M$2.19M$4.07M$3.02M$2.10M
Low Forecast$1.91M$1.91M$1.91M$1.91M$1.59M$1.27M$1.43M$629.98K$318.58K$955.75K$-335.41K$3.09M$944.97K$892.03K$424.80K$2.81M$5.29M$2.13M$3.12M$2.55M$4.26M$3.61M$3.06M$3.02M$2.62M$1.97M$2.19M$2.71M$3.02M$2.10M
Surprise %-------------3.41%30.29%0.61%-0.94%4.46%1.18%1.29%1.23%1.43%1.05%1.06%0.96%-4.48%0.76%0.80%0.88%1.06%

Global Medical REIT's average Quarter net income forecast for Dec 23 is $986.05K, with a range of $944.97K to $1.01M. GMRE's average Quarter net income forecast represents a -68.58% decrease compared to the company's last Quarter net income of $3.14M (Sep 23).

Global Medical REIT SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143122422211112222987655
SG&A-------------$4.37M$4.46M$3.80M$4.05M$3.96M$4.34M$4.20M$3.93M$3.85M$4.29M$4.38M$4.43M$16.61M$4.58M$4.34M$3.33M$3.30M
Avg Forecast$7.19M$7.06M$6.94M$6.81M$6.41M$6.34M$6.32M$6.18M$6.10M$6.05M$5.99M$6.09M$6.20M$6.28M$6.35M$5.54M$4.95M$5.65M$5.55M$5.04M$5.33M$5.10M$4.09M$4.48M$4.37M$3.84M$3.76M$14.50M$3.37M$3.06M
High Forecast$7.30M$7.17M$7.05M$6.92M$6.51M$6.44M$6.42M$6.37M$6.20M$6.06M$5.99M$7.31M$6.21M$6.28M$6.45M$6.65M$5.93M$5.65M$5.55M$6.04M$5.33M$5.10M$4.91M$4.48M$4.37M$3.84M$3.76M$17.40M$3.37M$3.06M
Low Forecast$7.02M$6.89M$6.77M$6.65M$6.26M$6.19M$6.17M$5.93M$5.96M$6.03M$5.99M$4.88M$6.20M$6.28M$6.20M$4.43M$3.96M$5.65M$5.55M$4.03M$5.33M$5.10M$3.27M$4.48M$4.37M$3.84M$3.76M$11.60M$3.37M$3.06M
Surprise %-------------0.70%0.70%0.69%0.82%0.70%0.78%0.83%0.74%0.76%1.05%0.98%1.01%4.33%1.22%0.30%0.99%1.08%

Global Medical REIT's average Quarter SG&A projection for Dec 23 is $6.20M, based on 4 Wall Street analysts, with a range of $6.20M to $6.21M. The forecast indicates a 42.05% rise compared to GMRE last annual SG&A of $4.37M (Sep 23).

Global Medical REIT EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143122422211112222987655
EPS-------------$0.05$0.18$0.01$-0.09$0.12$0.03$0.04$0.08$0.08$0.07$0.06$0.05$-0.19$0.04$0.06$0.07$0.06
Avg Forecast$0.03$0.03$0.03$0.03$0.03$0.02$0.02$0.01$0.01$0.01$-0.01$0.01$0.01$0.01$0.01$0.01$0.03$0.03$0.05$0.05$0.07$0.06$0.05$0.05$0.04$0.03$0.03$0.05$0.05$0.03
High Forecast$0.03$0.03$0.03$0.03$0.03$0.02$0.02$0.01$0.01$0.02$-0.00$0.01$0.02$0.01$0.01$0.02$0.03$0.03$0.05$0.05$0.07$0.06$0.05$0.05$0.04$0.03$0.03$0.05$0.05$0.03
Low Forecast$0.03$0.03$0.03$0.03$0.02$0.02$0.02$0.01-$0.01$-0.01-$0.01$0.01$0.01$0.01$0.03$0.03$0.05$0.05$0.07$0.06$0.05$0.05$0.04$0.03$0.03$0.05$0.05$0.03
Surprise %-------------3.42%27.00%0.67%-3.45%3.69%0.63%0.75%1.26%1.45%1.40%1.30%1.25%-6.33%1.20%1.26%1.52%1.88%

According to 4 Wall Street analysts, Global Medical REIT's projected average Quarter EPS for Dec 23 is $0.01, with a low estimate of $0.01 and a high estimate of $0.02. This represents a -68.68% decrease compared to GMRE previous annual EPS of $0.05 (Sep 23).

Global Medical REIT Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
GMREGlobal Medical REIT$8.64$11.7536.00%Buy
CHCTCommunity Healthcare Trust$18.39$22.3321.42%Buy
HRHealthcare Realty Trust$17.56$19.008.20%Buy
OHIOmega Healthcare Investors$39.88$38.62-3.16%Buy
VTRVentas$64.11$61.34-4.32%Buy
SBRASabra Health Care REIT$18.39$17.29-5.98%Hold
NHINational Health Investors$77.14$72.20-6.40%Hold
CTRECareTrust REIT$30.66$25.50-16.83%Buy

GMRE Forecast FAQ


Is Global Medical REIT a good buy?

Yes, according to 3 Wall Street analysts, Global Medical REIT (GMRE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of GMRE's total ratings.

What is GMRE's price target?

Global Medical REIT (GMRE) average price target is $11.75 with a range of $11.75 to $11.75, implying a 36.00% from its last price of $8.64. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Global Medical REIT stock go up soon?

According to Wall Street analysts' prediction for GMRE stock, the company can go up by 36.00% (from the last price of $8.64 to the average price target of $11.75), up by 36.00% based on the highest stock price target, and up by 36.00% based on the lowest stock price target.

Can Global Medical REIT stock reach $13?

GMRE's average twelve months analyst stock price target of $11.75 does not support the claim that Global Medical REIT can reach $13 in the near future.

What are Global Medical REIT's analysts' financial forecasts?

Global Medical REIT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $145.06M (high $147.84M, low $141.03M), average EBITDA is $99.34M (high $101.25M, low $96.58M), average net income is $5.09M (high $5.2M, low $4.93M), average SG&A $25.26M (high $25.74M, low $24.56M), and average EPS is $0.0775 (high $0.0791, low $0.075). GMRE's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $160.78M (high $163.31M, low $156.98M), average EBITDA is $110.11M (high $111.84M, low $107.5M), average net income is $7.89M (high $8.05M, low $7.65M), average SG&A $28M (high $28.44M, low $27.34M), and average EPS is $0.12 (high $0.122, low $0.116).

Did the GMRE's actual financial results beat the analysts' financial forecasts?

Based on Global Medical REIT's last annual report (Dec 2022), the company's revenue was $137.28M, beating the average analysts forecast of $127.95M by 7.30%. Apple's EBITDA was $96.49M, missing the average prediction of $97.55M by -1.09%. The company's net income was $-5.234M, missing the average estimation of $15.05M by -134.77%. Apple's SG&A was $16.54M, missing the average forecast of $21.18M by -21.90%. Lastly, the company's EPS was $-0.08, missing the average prediction of $0.161 by -149.74%. In terms of the last quarterly report (Sep 2023), Global Medical REIT's revenue was $35.51M, missing the average analysts' forecast of $36.05M by -1.52%. The company's EBITDA was $26.31M, beating the average prediction of $24.69M by 6.54%. Global Medical REIT's net income was $3.14M, beating the average estimation of $920.32K by 240.97%. The company's SG&A was $4.37M, missing the average forecast of $6.28M by -30.45%. Lastly, the company's EPS was $0.0479, beating the average prediction of $0.014 by 242.14%